Dominant missense mutations in and around the Aβ region of APP or in the catalytic component of γ-secretase (presenilin) are associated with early onset (<age 60 years) AD, and these mutations change the type or amount of Aβ to increase its tendency to aggregate. This evidence concerns the gene APP and Alzheimer disease.